Reconstitution Kit: Convenience in preparation.

  • Pre-assembled syringe with plunger attached
  • Secure syringe-to-vial connection
  • Vacuum seal for ease of drawing diluent into vial

See the INSTRUCTIONS FOR USE section of the IXINITY package insert for reconstitution, pooling, and administration instructions.

Watch Brian Rodgers reconstitute IXINITY.

Planet-friendly Packaging takes the patient’s world into account.

IXINITY comes in a fully collapsible, 100% recyclable carton.

Flexibility of IXINITY vial strengths.

IXINITY is available in 500, 1000, 1500, and 3000 IU single-use vials, which are color-coded by vial strength.1

To order IXINITY, call your IXperience Concierge™ at 1​-8​55​-I​XIN​ITY (1​-85​5-​49​4-​648​9).

IXINITY can be refrigerated or stored at room temperature.

  • Store at 2°–25°C (36°–77°F); do not freeze.1
  • Keep the vial in its carton and protect from light.1
  • The reconstituted solution should be infused immediately or within 3 hours of storage at room temperature after reconstitution.1
  • Do not refrigerate after reconstitution.1

Custom Ancillaries—patients choose at no additional cost.

Patients choose the ancillary supplies they want at no cost to you or them.

We worked with patients to figure out how to create flexibility that puts them in control of the ancillary supplies delivered with IXINITY. Butterfly needles, alcohol wipes, gauzes, bandages, tourniquets? Patients choose which—and how often—they get them delivered.

Whatever patients decide, there’s no cost to you or them. In fact, we all gain as we work together to improve the hemophilia B patient IXperience and reduce waste.

Custom Ancillaries include choice of:

  • Winged infusion sets
  • Sterile prep pad
  • Gauze
  • Bandages
  • Extra syringes
  • Flex wrap
  • Tourniquet
  • Other supplies as requested

To request Custom Ancillaries for your patients, please fill out the IXINITY Custom Ancillary Request Form and fax it to 1​-8​88​-7​47​-9​329 according to the instructions on the form.


Reference: 1. IXINITY [coagulation factor IX (recombinant)] prescribing information. Chicago, IL: Medexus Pharma, Inc.; September 2021. 2. Collins PW, Quon DVK, Makris M, et al. Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated Haemophilia. 2018;24:104-112. 3. Data on file. Chicago, IL: Medexus Pharma, Inc.